Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations

Fig. 1

IHC analysis of EHD1 expression and correlation between EHD1 and survival in NSCLC tissues. EHD1-negative (a:x100; bx400:) and EHD1-positive (c:x100;d:x400) tumour samples are shown. Tissue sections were stained with EHD1-specific antibodies, and an immunohistochemical analysis was conducted as described in the Materials and Methods. e: OS in NSCLC patients receiving adjuvant chemotherapy. Patients receiving post-operational adjuvant chemotherapy with positive EHD1 expression exhibited reduced OS (Pā€‰=ā€‰0.01)

Back to article page